Ixiaro Market Report 2026

Ixiaro Market Overview

• The Ixiaro market growth in the historic period has been driven by recurring japanese encephalitis outbreaks, increased international travel • Market expansion is supported by growth in travel medicine clinics, expanding vaccination coverage in asia-pacific • Growth Driver: The Increasing Incidence Of Japanese Encephalitis Fuels LXIARO Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ixiaro Market?

Ixiaro is a vaccine used to prevent Japanese encephalitis (JE), a mosquito-borne viral infection that can cause severe inflammation of the brain. It is formulated using inactivated Japanese encephalitis virus and is primarily recommended for travelers to areas where JE is endemic. The vaccine is administered in a two-dose schedule, typically given 28 days apart, and provides protection against the disease. The main vaccine types of ixiaro are cell culture-derived inactivated vaccines and others. Cell culture-derived inactivated vaccine is made using a virus that has been grown in a laboratory setting, specifically in cell cultures. The virus is then inactivated, meaning it can no longer cause disease but still stimulates the immune system to create a defense against the actual virus. The indications are Japanese encephalitis and others, and the patient demographics include pediatric patients, adult patients, and high-risk groups. The distribution channels are hospitals, private clinics, public health clinics, pharmacies, and mobile vaccination units, and it is used in various applications such as routine immunization, travel vaccination, and post-exposure prophylaxis.

What Is The Ixiaro Market Growth Forecast?

The growth in the forecast period can be attributed to growth in travel medicine clinics, expanding vaccination coverage in asia-pacific, rising awareness of vector-borne diseases, improved cold-chain infrastructure, increased public health funding. Major trends in the forecast period include rising travel vaccination demand, expansion of mosquito-borne disease prevention, growth in routine immunization programs, increased focus on endemic region protection, adoption of inactivated virus vaccines.

Global Ixiaro Market Segmentation

1) By Vaccine Type: Cell Culture-Derived Inactivated Vaccine, Other Types 2) By Indication: Japanese Encephalitis, Other Encephalitis Types 3) By Patient Demographics: Pediatric Patients, Adult Patients, High-Risk Groups 4) By Distribution Channel: Hospitals, Private Clinics, Public Health Clinics, Pharmacies

What Are The Drivers Of The Ixiaro Market?

The rising incidence of Japanese encephalitis is expected to propel the growth of the ixiaro market going forward. Japanese encephalitis is a viral infection transmitted by mosquitoes, causing severe neurological disease in some cases. The rising cases of Japanese Encephalitis (JE) are due to intensified rice irrigation, population growth, and increased pig farming, which create favorable conditions for mosquito breeding and virus transmission in endemic regions. Ixiaro, a vaccine developed to protect against Japanese encephalitis, is crucial in preventing the viral infection transmitted by mosquitoes, as it stimulates the immune system to produce antibodies that provide long-term protection against the disease, which can cause severe neurological damage and even death if left untreated. For instance, in August 2024, according to the World Health Organisation, a Switzerland-based United Nations agency, WHO estimates around 100,000 clinical cases of Japanese encephalitis occur globally each year, with approximately 25,000 deaths attributed to the disease. Therefore, the rising incidence of Japanese encephalitis is driving the ixiaro industry. The growing number of clinical trials is expected to fuel the expansion of the ixiaro market going foward. Clinical trials refer to structured research studies conducted to evaluate the effectiveness, safety, and potential side effects of medical treatments, drugs, or devices in humans. The increasing number of clinical trials reflects the growing complexity of healthcare needs, advancements in science, and the broader scope of medical research. Ixiaro, a Japanese encephalitis vaccine, supports clinical trials by enabling researchers to evaluate vaccine efficacy, safety, and immune responses in diverse populations, contributing to the development of effective treatments and improving trial outcomes in regions affected by the disease. For instance, in October 2024, according to ClinicalTrials.gov, a US-based government clinical trials registry, during 2023 a total of 39,710 new studies were registered, bringing the cumulative total to 477,203 studies by the end of 2023, compared to 38,023 new studies registered during 2022 which brought the cumulative total to 437,493 studies by the end of 2022. Therefore, the rising number of clinical trials is driving the growth of the ixiaro industry. Rising personalized medicine is expected to propel the growth of the ixiaro market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. The rising personalized medicine is due to advancements in genomic technologies, increased understanding of molecular biology, growing availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while minimizing side effects. Ixiaro, a vaccine developed to prevent Japanese Encephalitis, supports personalized medicine by offering tailored protection based on individual risk factors such as geographical exposure and health conditions, thereby enhancing the precision of immunization strategies for travelers and those in endemic areas. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, rising personalized medicine drives the ixiaro industry.

Key Players In The Global Ixiaro Market

Major companies operating in the ixiaro market are Valneva Austria GmbH

Regional Insights

North America was the largest region in the ixiaro market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ixiaro Market?

The Ixiaro market consists of sales of the Japanese encephalitis vaccine, dukoral for cholera, and enterotoxigenic escherichia coli (ETEC) diarrhea. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ixiaro Market Report 2026?

The ixiaro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ixiaro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.